- What do the recent FDA Guidelines on Patient-Focused Drug Development (PFDD) mean to us?
- Why do we need more patient focussed thinking and design of drug products, medical devices and combination products?
- How will become more patient focussed shake up the industry and make us more competitive
Diane Harper, Director Regulatory Affairs-CMC, Merck
Galen Shi, Senior Engineering Advisor, Eli Lilly
Graham Jones, Director of Innovation, Novartis
Paul Upham, Head, Smart Devices, Genentech